Yaron Conforti's guest appearances

Yaron Conforti

The Psychedelic Podcast

The Green Rush is real.

Agoracom Small Cap CEO Interviews

PsyFi

Psychedelic Spotlight Podcast

Timothy Ko

Lauren Taus

Zoe Helene

Chris Kilham

Rick Doblin

Sam Chapman

Doug Drysdale

Ingmar Gorman

Ed Prideaux

Paul Austin

Trevor Millar

Payton Nyquvest

Adam Levin

Lynn Marie Morski

Kyle Kingsbury

OwlTail

No new episode of the Green Rush this week, instead we’re replaying an old favorite, our conversation with Yaron Conforti, CEO and Director of Novamind Ventures, which delivers psychedelic therapies to patients suffering from treatment resistant psychological conditions at its Cedar Psychiatry clinics in Utah. Novamind is evolving the model of regulated psychedelic medicine by treating patients with ketamine-assisted psychotherapy at its four Cedar Psychiatry clinics in Utah; creating complementary evidence-based therapy modalities that enhance patient outcomes; and, building a network of outpatient mental health clinics and clinical research sites in jurisdictions with established regulations for the use of psychedelics. Our hosts Anne and Nick spoke with Yaron to chat with him about the more than 4,000 ketamine-assisted psychotherapy treatments Novamind has administered, the Company’s expansion plans beyond its home base of Utah and Novamind’s RTO onto the CSE.And no worries, we will be back with a brand new episode next week – so don’t lean back, lean and enjoy! Yaron Conforti, Chief Executive Officer of NovamindYaron Conforti is the Chief Executive Officer and Director of Novamind. He’s an entrepreneur and the principal of Emmcap Corp., an investor in venture-stage companies. Previously, he served in senior investment banking roles at Desjardins Securities and Sandfire Securities, and in CEO, CFO and corporate director roles for private and public companies.Links and mentions in the show https://novamind.ca/  Links to the guest’s company and social media accounts Novamind LinkedIn: https://www.linkedin.com/company/novamind-inc/ Novamind Instagram: https://www.linkedin.com/company/novamind-inc/ Novamind Twitter: https://twitter.com/Novamind_Inc Novamind Facebook: https://www.facebook.com/novamindinc Yaron Conforti LinkedIn: https://www.linkedin.com/in/yaron-conforti-venture-capital/  Show Credits:This episode was hosted by Anne Donohoe and Nick Opich of KCSA Strategic Communications.Special thanks to our Program Director Shea Gunther.You can learn more about how KCSA Cannabis can help your cannabiz by visiting www.kcsa-cannabis.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels:Twitter: @The_GreenRush Instagram: @thegreenrush_podcastLinkedIn: https://www.linkedin.com/company/thegreenrushpodcast/ Facebook: https://www.facebook.com/TheGreenRushPodcast/ YouTube: https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

No new episode of the Green Rush this week, instead we’re replaying an old favorite, our conversation with Yaron Conforti, CEO and Director of Novamind Ventures, which delivers psychedelic therapies to patients suffering from treatment resistant psychological conditions at its Cedar Psychiatry clinics in Utah. Novamind is evolving the model of regulated psychedelic medicine by treating patients with ketamine-assisted psychotherapy at its four Cedar Psychiatry clinics in Utah; creating complementary evidence-based therapy modalities that enhance patient outcomes; and, building a network of outpatient mental health clinics and clinical research sites in jurisdictions with established regulations for the use of psychedelics. Our hosts Anne and Nick spoke with Yaron to chat with him about the more than 4,000 ketamine-assisted psychotherapy treatments Novamind has administered, the Company’s expansion plans beyond its home base of Utah and Novamind’s RTO onto the CSE.And no worries, we will be back with a brand new episode next week – so don’t lean back, lean and enjoy! Yaron Conforti, Chief Executive Officer of NovamindYaron Conforti is the Chief Executive Officer and Director of Novamind. He’s an entrepreneur and the principal of Emmcap Corp., an investor in venture-stage companies. Previously, he served in senior investment banking roles at Desjardins Securities and Sandfire Securities, and in CEO, CFO and corporate director roles for private and public companies.Links and mentions in the show<ul> <li><a href="https://novamind.ca/" rel="nofollow" target="_blank">https://novamind.ca/</a> </li> </ul>Links to the guest’s company and social media accounts<ul> <li>Novamind LinkedIn:<a href="https://www.linkedin.com/company/novamind-inc/" rel="nofollow" target="_blank"> https://www.linkedin.com/company/novamind-inc/</a></li> <li>Novamind Instagram:<a href="https://www.linkedin.com/company/novamind-inc/" rel="nofollow" target="_blank"> https://www.linkedin.com/company/novamind-inc/</a></li> <li>Novamind Twitter:<a href="https://twitter.com/Novamind_Inc" rel="nofollow" target="_blank"> https://twitter.com/Novamind_Inc</a></li> <li>Novamind Facebook:<a href="https://www.facebook.com/novamindinc" rel="nofollow" target="_blank"> https://www.facebook.com/novamindinc</a></li> <li>Yaron Conforti LinkedIn: <a href="https://www.linkedin.com/in/yaron-conforti-venture-capital/" rel="nofollow" target="_blank">https://www.linkedin.com/in/yaron-conforti-venture-capital/</a> </li> </ul>Show Credits:This episode was hosted by Anne Donohoe and Nick Opich of KCSA Strategic Communications.Special thanks to our Program Director Shea Gunther.You can learn more about how KCSA Cannabis can help your cannabiz by visiting<a href="http://www.kcsa-cannabis.com" rel="nofollow" target="_blank"> www.kcsa-cannabis.com</a> or emailing greenrush@kcsa.com. You can also connect with us via our social channels:Twitter: <a href="https://twitter.com/The_GreenRush" rel="nofollow" target="_blank">@The_GreenRush </a>Instagram: <a href="https://www.instagram.com/thegreenrush_podcast/" rel="nofollow" target="_blank">@thegreenrush_podcast</a>LinkedIn: <a href="https://www.linkedin.com/company/thegreenrushpodcast/" rel="nofollow" target="_blank">https://www.linkedin.com/company/thegreenrushpodcast/</a> Facebook: <a href="https://www.facebook.com/TheGreenRushPodcast/" rel="nofollow" target="_blank">https://www.facebook.com/TheGreenRushPodcast/</a> YouTube:<a href="https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true" rel="nofollow" target="_blank"> https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true</a>

Yaron Conforti, CEO of Novamind

There’s a growing momentum to legalize therapeutic psychedelics in the United States, with clinics nationwide already offering ketamine therapy, as well as the recent decriminalization of psilocybin in Oregon. What do today’s treatment protocols look like, and what will the future bring? In this episode, Yaron Conforti, CEO and Director of Novamind, talks with Paul Austin, founder of Third Wave, about creating individualized treatment plans, the thousands of clinics we can expect in the next ten years, and democratizing access to psychedelic medicine.

There’s a growing momentum to legalize therapeutic psychedelics in the United States, with clinics nationwide already offering ketamine therapy, as well as the recent decriminalization of psilocybin in Oregon. What do today’s treatment protocols look like, and what will the future bring? In this episode, Yaron Conforti, CEO and Director of Novamind, talks with Paul Austin, founder of Third Wave, about creating individualized treatment plans, the thousands of clinics we can expect in the next ten years, and democratizing access to psychedelic medicine.

Yaron Conforti - Building the Infrastructure for Our Psychedelic Future

To learn more about Novamind and the work they're doing be sure to visit their website, Novamind.ca. Investors can find them on the Canadian Securities Exchange under the symbol NM.Get the latest industry news around all things psychedelics by visiting our website, PsychedelicSpotlight.com, and be sure to subscribe to our newsletter to never miss a thing.This interview was recorded on January 12, 2021.

To learn more about Novamind and the work they're doing be sure to visit their website, <a href="novamind.ca" rel="nofollow" target="_blank">Novamind.ca</a>. Investors can find them on the <a href="https://www.thecse.com/" rel="nofollow" target="_blank">Canadian Securities Exchange</a> under the symbol <a href="https://www.thecse.com/en/listings/novamind-inc" rel="nofollow" target="_blank">NM</a>.Get the latest industry news around all things psychedelics by visiting our website, <a href="https://psychedelicspotlight.com/" rel="nofollow" target="_blank">PsychedelicSpotlight.com</a>, and be sure to subscribe to our newsletter to never miss a thing.This interview was recorded on January 12, 2021.

Yaron Conforti, Novamind

Yaron Conforti, CEO and Director of Novamind Ventures (CSE: NM), which delivers psychedelic therapies to patients suffering from treatment resistant psychological conditions at its Cedar Psychiatry clinics in Utah, is this week’s special guest on The Green Rush. Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine.As the psychedelic renaissance continues to take shape, our hosts Anne and Nick sat down with Yaron to chat with him about the more than 4,000 ketamine-assisted psychotherapy treatments Novamind has administered, the Company’s expansion plans beyond its home base of Utah and Novamind’s RTO onto the CSE. As psychedelic investors look for opportunities, they won’t want to miss this interview with Yaron as he delves into how his company is focused on execution and bringing these next-generation treatments to the masses. So don’t sit back, lean forward and enjoy!Yaron Conforti, Chief Executive Officer of NovamindYaron Conforti is the Chief Executive Officer and Director of Novamind. He’s an entrepreneur and the principal of Emmcap Corp., an investor in venture-stage companies. Previously, he served in senior investment banking roles at Desjardins Securities and Sandfire Securities, and in CEO, CFO and corporate director roles for private and public companies.Links and mentions in the show https://novamind.ca/  Links to the guest’s company and social media accounts Novamind LinkedIn: https://www.linkedin.com/company/novamind-inc/ Novamind Instagram: https://www.linkedin.com/company/novamind-inc/ Novamind Twitter: https://twitter.com/Novamind_Inc Novamind Facebook: https://www.facebook.com/novamindinc Yaron Conforti LinkedIn: https://www.linkedin.com/in/yaron-conforti-venture-capital/  Show Credits:This episode was hosted by Anne Donohoe and Nick Opich of KCSA Strategic Communications.Special thanks to our Program Director Shea Gunther.You can learn more about how KCSA Cannabis can help your cannabiz by visiting www.kcsa-cannabis.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels:Twitter: @The_GreenRush Instagram: @thegreenrush_podcastLinkedIn: https://www.linkedin.com/company/thegreenrushpodcast/ Facebook: https://www.facebook.com/TheGreenRushPodcast/ YouTube: https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

Yaron Conforti, CEO and Director of Novamind Ventures (CSE: NM), which delivers psychedelic therapies to patients suffering from treatment resistant psychological conditions at its Cedar Psychiatry clinics in Utah, is this week’s special guest on The Green Rush. Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine.As the psychedelic renaissance continues to take shape, our hosts Anne and Nick sat down with Yaron to chat with him about the more than 4,000 ketamine-assisted psychotherapy treatments Novamind has administered, the Company’s expansion plans beyond its home base of Utah and Novamind’s RTO onto the CSE. As psychedelic investors look for opportunities, they won’t want to miss this interview with Yaron as he delves into how his company is focused on execution and bringing these next-generation treatments to the masses. So don’t sit back, lean forward and enjoy!Yaron Conforti, Chief Executive Officer of NovamindYaron Conforti is the Chief Executive Officer and Director of Novamind. He’s an entrepreneur and the principal of Emmcap Corp., an investor in venture-stage companies. Previously, he served in senior investment banking roles at Desjardins Securities and Sandfire Securities, and in CEO, CFO and corporate director roles for private and public companies.Links and mentions in the show<ul> <li><a href="https://novamind.ca/" rel="nofollow" target="_blank">https://novamind.ca/</a> </li> </ul>Links to the guest’s company and social media accounts<ul> <li>Novamind LinkedIn:<a href="https://www.linkedin.com/company/novamind-inc/" rel="nofollow" target="_blank"> https://www.linkedin.com/company/novamind-inc/</a></li> <li>Novamind Instagram:<a href="https://www.linkedin.com/company/novamind-inc/" rel="nofollow" target="_blank"> https://www.linkedin.com/company/novamind-inc/</a></li> <li>Novamind Twitter:<a href="https://twitter.com/Novamind_Inc" rel="nofollow" target="_blank"> https://twitter.com/Novamind_Inc</a></li> <li>Novamind Facebook:<a href="https://www.facebook.com/novamindinc" rel="nofollow" target="_blank"> https://www.facebook.com/novamindinc</a></li> <li>Yaron Conforti LinkedIn: <a href="https://www.linkedin.com/in/yaron-conforti-venture-capital/" rel="nofollow" target="_blank">https://www.linkedin.com/in/yaron-conforti-venture-capital/</a> </li> </ul>Show Credits:This episode was hosted by Anne Donohoe and Nick Opich of KCSA Strategic Communications.Special thanks to our Program Director Shea Gunther.You can learn more about how KCSA Cannabis can help your cannabiz by visiting<a href="http://www.kcsa-cannabis.com" rel="nofollow" target="_blank"> www.kcsa-cannabis.com</a> or emailing greenrush@kcsa.com. You can also connect with us via our social channels:Twitter: <a href="https://twitter.com/The_GreenRush" rel="nofollow" target="_blank">@The_GreenRush </a>Instagram: <a href="https://www.instagram.com/thegreenrush_podcast/" rel="nofollow" target="_blank">@thegreenrush_podcast</a>LinkedIn: <a href="https://www.linkedin.com/company/thegreenrushpodcast/" rel="nofollow" target="_blank">https://www.linkedin.com/company/thegreenrushpodcast/</a> Facebook: <a href="https://www.facebook.com/TheGreenRushPodcast/" rel="nofollow" target="_blank">https://www.facebook.com/TheGreenRushPodcast/</a> YouTube:<a href="https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true" rel="nofollow" target="_blank"> https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true</a>